Fitzbio Research HubEducational content only — not medical advice

Melanocortin research

Melanotan II

An unapproved synthetic melanocortin analogue used in laboratory research.

34 connected records34 graded citations0 external identifiers

Research context

An unapproved synthetic melanocortin analogue used in laboratory research.

Regulatory note: Verify local laws, product approval and professional guidance before any human use. This profile is not a recommendation for use.

Evidence map

Claims linked to original records.

Evidence levels describe study design. They do not by themselves establish safety or effectiveness.

Not yet classified

Robert T. Dorr, Ruskin R. Lines, Norman S. Levine, Christine A. Brooks, Li Xiang, Victor J. Hruby et al. · Life Sciences · 135 citations

Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study

openalex 1996
Not yet classified

M. Kilpeläinen, Juha Mönkäre, Maria A. Vlasova, Joakim Riikonen, Vesa‐Pekka Lehto, Jarno Salonen et al. · European Journal of Pharmaceutics and Biopharmaceutics · 64 citations

Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery

openalex 2010
Not yet classified

Kasper Fjellhaugen Hjuler, Henrik Frank Lorentzen · Dermatology · 31 citations

Melanoma Associated with the Use of Melanotan-II

openalex 2013
Not yet classified

Michael E. Nelson, Sean M. Bryant, Steven E. Aks · Clinical Toxicology · 34 citations

Melanotan II injection resulting in systemic toxicity and rhabdomyolysis

openalex 2012
Not yet classified

Annemieke C. Heijboer, Anita M. van den Hoek, Hanno Pijl, Peter J. Voshol, Louis M. Havekes, Johannes Anthonius Romijn et al. · Diabetologia · 43 citations

Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice

openalex 2005
Not yet classified

Anne‐Sophie Rössler, James G. Pfaus, Hossein Kami Kia, J. Bernabé, L Alexandre, François Giuliano · Pharmacology Biochemistry and Behavior · 44 citations

The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat

openalex 2006
Not yet classified

Torben Breindahl, Michael J. Evans-Brown, Peter Hindersson, Jim McVeigh, Mark A Bellis, Allan Stensballe et al. · Drug Testing and Analysis · 34 citations

Identification and characterization by LC‐UV‐MS/MS of melanotan II skin‐tanning products sold illegally on the Internet

openalex 2014
Not yet classified

Weirath NA, Haskell-Luevano C

Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).

pubmed
Not yet classified

· American Chemical Society (ACS)

CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

crossref
Not yet classified

· American Chemical Society (ACS)

CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

crossref
Not yet classified

· American Chemical Society (ACS)

CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

crossref
Not yet classified

&NA; · Springer Science and Business Media LLC

Melanotan II

crossref 2012
Not yet classified

· Springer Science and Business Media LLC

Melanotan-II

crossref 2015
Not yet classified

Bonchev A

Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.

pubmed
Not yet classified

Yassin Alsabbagh A, Bhujel N, Singh RP

Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?

pubmed 2025
Not yet classified

Inozemtseva LS, Yatsenko KA, Glazova NY, Kamensky AA, Myasoedov NF, Levitskaya NG, Grivennikov IA, Dolotov OV

Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.

pubmed
Not yet classified

Deville M, Charlier C

Barbie drug identification: Not a child's play.

pubmed 2024
Not yet classified

Liu H, Liu Z, Wong HK, Xu N, Liu Q, Li Y, Liu Y, Wong H, Burt ME, Jossy SV, Han J, He Y

Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.

pubmed
Not yet classified

Castro G, Mendes NF, Weissmann L, Quaresma PGF, Saad MJA, Prada PO

Multiple metabolic signals in the CeA regulate feeding: The role of AMPK.

pubmed
Not yet classified

Todorovic M, Blanc A, Wang Z, Lozada J, Froelich J, Zeisler J, Zhang C, Merkens H, Benard F, Perrin DM

5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.

pubmed
Clinical trial

This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard NB-UVB phototherapy for repigmentation in adults with stable nonsegmental vitiligo.

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

clinicaltrials 2026
Not yet classified

Grant B, Kean J, de Silva NL, Aguilera R, Quinton OCB, Gumssani M, Bassett P, Dhillo WS, Lingford-Hughes A, Wolff K, Jayasena CN · The Journal of clinical endocrinology and metabolism

Clinical features of androgen abuse withdrawal in men during the first year of cessation: a community dwelling study.

pmc
Not yet classified

Resnick G, Khajeh-Afzaly M, Yousefian F, Raza A, Issa NT · The Journal of clinical and aesthetic dermatology

Insights into Tanning Biology and Tanning Products.

pmc 2026
Not yet classified

Liu H, Liu Z, Wong HK, Xu N, Liu Q, Li Y, Liu Y, Wong H, Burt ME, Jossy SV, Han J, He Y · Endocrinology

Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.

pmc
Not yet classified

Bonchev A · Life (Basel, Switzerland)

Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.

pmc
Not yet classified

Lawton SBR, Wagner VA, Nakagawa P, Segar JL, Sigmund CD, Morselli LL, Grobe JL · Hypertension (Dallas, Tex. : 1979)

Angiotensin in the Arcuate: Mechanisms Integrating Cardiometabolic Control: The 2022 COH Mid-Career Award for Research Excellence.

pmc 2024
Not yet classified

Côté I, Green SM, Morgan D, Carter CS, Tümer N, Scarpace PJ · Canadian journal of physiology and pharmacology

Activation of the central melanocortin system in rats persistently reduces body and fat mass independently of caloric reduction.

pmc 2018
Not yet classified

Weirath NA, Haskell-Luevano C · ACS pharmacology & translational science

Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).

pmc
Not yet classified

· Springer Science and Business Media LLC

Melanotan ii

crossref 2026
Not yet classified

&NA; · Springer Science and Business Media LLC

Melanotan II

crossref 2012
Not yet classified

&NA; · Springer Science and Business Media LLC

Melanotan II overdose

crossref 2012
Not yet classified

Hunter Wessells, Norman S. Levine, M E Hadley, R T Dorr, Victor J. Hruby · International Journal of Impotence Research · 118 citations

Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II

openalex 2000
Not yet classified

Moiz A, O'Keefe EL, O'Keefe JH

Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.

pubmed
Not yet classified

Moiz A, O'Keefe EL, O'Keefe JH · Missouri medicine

Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.

pmc

Connected data hub

Records with source provenance.

Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.

Clinical Trial

1 records
clinicaltrialsAdmin reviewed

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard NB-UVB phototherapy for repigmentation in adults with stable nonsegmental vitiligo.

NCT074375602026-02-22

Scholarly Work

8 records
crossrefAutomated import

Melanotan ii

· Springer Science and Business Media LLC

10.1007/s40278-026-93507-72026-03-28
crossrefAutomated import

Melanotan-II

· Springer Science and Business Media LLC

10.1007/s40278-015-0948-42015-05-01
crossrefAutomated import

Melanotan II

&NA; · Springer Science and Business Media LLC

10.2165/00128415-201214260-001092012-11-01
crossrefAutomated import

Melanotan II overdose

&NA; · Springer Science and Business Media LLC

10.2165/00128415-201214260-001112012-11-01
crossrefAutomated import

Melanotan II

&NA; · Springer Science and Business Media LLC

10.2165/00128415-201213950-000952012-03-01
crossrefAutomated import

CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

· American Chemical Society (ACS)

10.1021/acs.jmedchem.1c01848.s00127 Sep 2026
crossrefAutomated import

CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

· American Chemical Society (ACS)

10.1021/acs.jmedchem.1c01848.s00327 Sep 2026
crossrefAutomated import

CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

· American Chemical Society (ACS)

10.1021/acs.jmedchem.1c01848.s00227 Sep 2026

Open Access Article

8 records
pmcAutomated import

Insights into Tanning Biology and Tanning Products.

Resnick G, Khajeh-Afzaly M, Yousefian F, Raza A, Issa NT · The Journal of clinical and aesthetic dermatology

PMC130164512026-02-01
pmcAutomated import

Angiotensin in the Arcuate: Mechanisms Integrating Cardiometabolic Control: The 2022 COH Mid-Career Award for Research Excellence.

Lawton SBR, Wagner VA, Nakagawa P, Segar JL, Sigmund CD, Morselli LL, Grobe JL · Hypertension (Dallas, Tex. : 1979)

PMC114832142024-11-01
pmcAutomated import

Activation of the central melanocortin system in rats persistently reduces body and fat mass independently of caloric reduction.

Côté I, Green SM, Morgan D, Carter CS, Tümer N, Scarpace PJ · Canadian journal of physiology and pharmacology

PMC124121812018-03-01
pmcAutomated import

Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.

Moiz A, O'Keefe EL, O'Keefe JH · Missouri medicine

PMC1358500627 Sep 2026
pmcAutomated import

Clinical features of androgen abuse withdrawal in men during the first year of cessation: a community dwelling study.

Grant B, Kean J, de Silva NL, Aguilera R, Quinton OCB, Gumssani M, Bassett P, Dhillo WS, Lingford-Hughes A, Wolff K, Jayasena CN · The Journal of clinical endocrinology and metabolism

PMC1346695927 Sep 2026
pmcAutomated import

Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.

Liu H, Liu Z, Wong HK, Xu N, Liu Q, Li Y, Liu Y, Wong H, Burt ME, Jossy SV, Han J, He Y · Endocrinology

PMC1278553327 Sep 2026
pmcAutomated import

Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.

Bonchev A · Life (Basel, Switzerland)

PMC1294221127 Sep 2026
pmcAutomated import

Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).

Weirath NA, Haskell-Luevano C · ACS pharmacology & translational science

PMC1140669327 Sep 2026

Publication

9 records
pubmedAutomated import

Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?

Yassin Alsabbagh A, Bhujel N, Singh RP

402105732025-09-01
pubmedAutomated import

Barbie drug identification: Not a child's play.

Deville M, Charlier C

393020052024-11-01
pubmedAutomated import

Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.

Bonchev A

4175290227 Sep 2026
pubmedAutomated import

Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.

Inozemtseva LS, Yatsenko KA, Glazova NY, Kamensky AA, Myasoedov NF, Levitskaya NG, Grivennikov IA, Dolotov OV

3944274627 Sep 2026
pubmedAutomated import

Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).

Weirath NA, Haskell-Luevano C

3929625927 Sep 2026
pubmedAutomated import

Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.

Liu H, Liu Z, Wong HK, Xu N, Liu Q, Li Y, Liu Y, Wong H, Burt ME, Jossy SV, Han J, He Y

3881508627 Sep 2026
pubmedAutomated import

Multiple metabolic signals in the CeA regulate feeding: The role of AMPK.

Castro G, Mendes NF, Weissmann L, Quaresma PGF, Saad MJA, Prada PO

3860454927 Sep 2026
pubmedAutomated import

Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.

Moiz A, O'Keefe EL, O'Keefe JH

4275729027 Sep 2026
pubmedAutomated import

5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.

Todorovic M, Blanc A, Wang Z, Lozada J, Froelich J, Zeisler J, Zhang C, Merkens H, Benard F, Perrin DM

3828552716 Sep 2026

Article

8 records
openalexAutomated import

Identification and characterization by LC‐UV‐MS/MS of melanotan II skin‐tanning products sold illegally on the Internet

Torben Breindahl, Michael J. Evans-Brown, Peter Hindersson, Jim McVeigh, Mark A Bellis, Allan Stensballe et al. · Drug Testing and Analysis · 34 citations

10.1002/dta.16552014-04-25
openalexAutomated import

Melanoma Associated with the Use of Melanotan-II

Kasper Fjellhaugen Hjuler, Henrik Frank Lorentzen · Dermatology · 31 citations

10.1159/0003563892013-12-18
openalexAutomated import

Melanotan II injection resulting in systemic toxicity and rhabdomyolysis

Michael E. Nelson, Sean M. Bryant, Steven E. Aks · Clinical Toxicology · 34 citations

10.3109/15563650.2012.7406372012-11-05
openalexAutomated import

Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery

M. Kilpeläinen, Juha Mönkäre, Maria A. Vlasova, Joakim Riikonen, Vesa‐Pekka Lehto, Jarno Salonen et al. · European Journal of Pharmaceutics and Biopharmaceutics · 64 citations

10.1016/j.ejpb.2010.10.0042010-10-21
openalexAutomated import

The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat

Anne‐Sophie Rössler, James G. Pfaus, Hossein Kami Kia, J. Bernabé, L Alexandre, François Giuliano · Pharmacology Biochemistry and Behavior · 44 citations

10.1016/j.pbb.2006.09.0232006-11-01
openalexAutomated import

Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice

Annemieke C. Heijboer, Anita M. van den Hoek, Hanno Pijl, Peter J. Voshol, Louis M. Havekes, Johannes Anthonius Romijn et al. · Diabetologia · 43 citations

10.1007/s00125-005-1838-82005-06-22
openalexAutomated import

Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II

Hunter Wessells, Norman S. Levine, M E Hadley, R T Dorr, Victor J. Hruby · International Journal of Impotence Research · 118 citations

10.1038/sj.ijir.39005822000-10-01
openalexAutomated import

Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study

Robert T. Dorr, Ruskin R. Lines, Norman S. Levine, Christine A. Brooks, Li Xiang, Victor J. Hruby et al. · Life Sciences · 135 citations

10.1016/0024-3205(96)00160-91996-04-01
Responsible use of information

Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.